A randomized study of the effects of adenine arabinoside 5′-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication-Reference-Cited by-同舟云学术

A randomized study of the effects of adenine arabinoside 5′-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication

Published:1985-11 Issue:6 Volume:5 Page:1132-1138
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Lok Anna S. F.,Novick David M.,Karayiannis Peter,Dunk Arthur A.,Sherlock Sheila,Thomas Howard C.

Publisher

Wiley

Subject

Hepatology

Reference27 articles.

1. Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine Arabinoside

2. Antiviral treatment of chronic hepatitis B virus infection: Improvement in liver disease with interferon and adenine arabinoside

3. Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication

4. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: A controlled study

5. Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress in hepatitis B: A 30-year journey through three continents;Hepatology;2014-05-28

2. Demonstration of an association between detection of IgG antibody reactivity towards the C-terminal region of the preS1 protein of hepatitis B virus and the capacity to respond to interferon therapy in chronic hepatitis B;Journal of Gastroenterology and Hepatology;2008-05

3. Short report: prednisolone withdrawal followed by lymphoblastoid interferon in the therapy of adult patients with presumed childhood-acquired chronic hepatitis B virus infection;Alimentary Pharmacology & Therapeutics;2007-03-31

4. Personal view: the management of chronic hepatitis B infection;Alimentary Pharmacology and Therapeutics;2006-04

5. Treatment of HBe Antigen-Positive Chronic Hepatitis B;Seminars in Liver Disease;2003